HCTI Healthcare Triangle, Inc.
Services-Computer Integrated Systems Design · Nasdaq · SEC CIK 1839285 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY141.9%
TTM net income YoY-179.2%
TTM EPS YoY112.9%
Revenue 3-yr CAGR-5.8%
Net income 3-yr CAGR—
Margins
Gross margin548.0%
Operating margin-45.2%
Net margin-56.4%
FCF margin—
EBITDA margin-38.6%
Returns
ROE-59.7%
ROA-40.8%
ROIC (approx.)-32.6%
Asset turnover0.72x
Leverage & solvency
Liabilities / assets30.9%
Debt / equity0.26x
Current ratio0.62x
Interest coverage-40.05x
Cash quality & payout
Operating cash flow / net income0.97x
Accruals ratio-1.4%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $9.12M | $9.19M | $9.86M | $3.14M | $3.49M | $3.56M | $3.70M | $2.19M |
| Cost of revenue | $7.04M | $7.13M | $7.46M | $2.69M | $2.87M | $3.06M | $3.38M | $1.93M |
| Gross profit | $2.08M | $2.07M | $2.39M | $165.00M | $618,000 | $494,000 | $1.07B | $0 |
| R&D expense | $231,000 | $51,000 | $85,000 | $279,000 | $59,000 | $55,000 | $144,000 | -$80,000 |
| SG&A expense | $2.21M | $4.82M | $3.22M | $2.87M | $2.08M | $1.18M | $1.20M | $793,000 |
| Operating income | -$2.00M | -$4.07M | -$3.62M | -$4.44M | -$2.59M | -$1.36M | -$1.40M | -$498,000 |
| Interest expense | $80,000 | $84,000 | $89,000 | $100,000 | $151,000 | $0 | $316,000 | — |
| Pretax income | -$2.55M | -$4.39M | -$6.20M | -$4.50M | -$1.91M | -$1.37M | -$1.70M | -$1.34M |
| Income tax | -$14,000 | $24,000 | — | — | — | — | — | $4,000 |
| Net income | -$2.53M | -$4.42M | -$6.20M | -$4.50M | -$1.91M | -$1.37M | -$1.70M | -$1.35M |
| EBITDA | -$1.93M | -$3.54M | -$2.81M | -$3.81M | -$2.53M | -$1.36M | -$1.39M | -$643,000 |
| EPS (basic) | 1.70 | -1.56 | -6.81 | — | -509.53 | -35.01 | -0.17 | — |
| EPS (diluted) | 1.21 | -1.56 | -6.81 | — | -509.53 | -35.01 | -0.17 | — |
| Weighted avg. shares (diluted) | 872,744 | 2.81M | 930,672 | — | 4.44M | 39,057 | 659 | — |
| Banking | ||||||||
| Net interest income | -$80,000 | -$89,000 | -$85,000 | -$100,000 | -$32,000 | -$21,000 | -$413,000 | -$853,000 |
| Balance sheet | ||||||||
| Cash & equivalents | $1.87M | $1.91M | $4.32M | $7.62M | $1.63M | $3.23M | $6.83M | $20,000 |
| Receivables | $4.79M | $6.19M | $8.37M | $2.07M | $2.44M | $1.86M | $1.91M | $1.11M |
| Current assets | $8.86M | $9.65M | $18.89M | $13.15M | $7.94M | $8.87M | $9.84M | $1.45M |
| PP&E, net | $1.09M | $1.19M | $1.33M | $5,000 | $5,000 | $3,000 | — | $12,000 |
| Goodwill | $2.95M | $2.95M | $2.95M | $2.95M | — | — | — | — |
| Intangibles | $1.88M | $4.69M | $5.22M | $2.81M | $191,000 | — | — | — |
| Total assets | $72.70M | $73.64M | $80.16M | $22.74M | $13.84M | $14.57M | $11.79M | $1.96M |
| Current liabilities | $14.38M | $15.99M | $20.99M | $12.79M | $3.91M | $3.16M | $3.21M | $7.08M |
| Short-term debt | $5.14M | $5.44M | $7.84M | $10.74M | $1.53M | $415,000 | $775,000 | $2.65M |
| Long-term debt | $7.78M | $8.10M | $629,000 | — | — | — | — | — |
| Total debt | $12.92M | $13.54M | $8.47M | — | — | — | — | — |
| Total liabilities | $22.46M | $24.54M | $27.46M | $12.79M | $5.11M | $4.36M | $3.21M | $7.08M |
| Shareholders' equity | $50.39M | $49.19M | $52.76M | $9.98M | $8.74M | $10.21M | $8.58M | -$5.11M |
| Net debt | $11.05M | $11.64M | $4.15M | — | — | — | — | — |
| Shares outstanding | 886,497 | 2.03M | 1.85M | 7,121 | 4.44M | 5.83M | 16.04M | 380 |
| Cash flow statement | ||||||||
| Operating cash flow | -$2.51M | -$833,000 | -$6.86M | -$6.83M | -$1.50M | -$2.63M | -$5.56M | -$811,000 |
| Capital expenditure | — | — | $22,000 | $0 | $3,000 | — | — | — |
| Free cash flow | — | — | -$6.89M | -$6.83M | -$1.50M | — | — | — |
| Investing cash flow | -$1.46M | -$3.22M | -$6.02M | -$462,000 | -$686,000 | — | — | — |
| Financing cash flow | $3.98M | $1.71M | $9.48M | $13.29M | $584,000 | -$360,000 | $12.36M | $803,000 |
| Depreciation & amortization | $74,000 | $529,000 | $810,000 | $630,000 | $63,000 | $0 | $12,000 | -$145,000 |
| Stock-based compensation | — | — | — | $0 | $415,000 | $0 | $36,000 | -$19,000 |
Free plan shows the latest 8 periods; Pro shows all 25 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.